Drugs administered by the patients without the help of medical professionals are referred to as self-administered drugs. Self-administered drugs such as topical prescription drugs, over-the-counter drugs, and self-administered intravenous drugs are mainly consumed by patients suffering from chronic diseases such as multiple sclerosis, rheumatoid arthritis, diabetes and others. The rising prevalence of chronic diseases globally is expected to boost the demand for self-administered drugs, mainly among the geriatric and working populace. As per WHO, by 2050, the worldâs aged population (60 years and older) is expected to reach the 2 billion mark, up from 900 million in 2015.
Market Determinants
The key factor driving the growth of global self-administered drugs market is the increasing outpatient services. The changing life style of people encourages them to opt for outpatient services, which in turn fuels the market growth. Moreover, the rising number of diabetic patients, and the government insurance organizations are also driving the growth of global self-administered drugs market. According to WHO, 422 million adults have diabetes worldwide. Such a huge pool of diabetic patients is expected to increase the demand for self-administered drugs. On the other hand, side effects caused due to improper dosage, along with low or zero reimbursement are hindering the market of self-administered drugs. However, innovations in medical science, and increasing awareness regarding self-administered drugs are expected to create huge opportunities for the growth of market in the upcoming years.
SELF-ADMINISTERED DRUGS MARKET SEGMENTATION
By Product Type
⢠Injectable drugs
⢠Inhaled drugs
By Mode of Administration
⢠Oral
⢠Transdermal
⢠Intravenous
⢠Nasal
By Application
⢠Diabetes
⢠Hormone replacement
⢠Cardiovascular ailment
⢠Pain management
⢠Osteoporosis
⢠Others
By Geography
⢠North America
⢠Europe
⢠Asia-Pacific
⢠Rest of the World